BCL-2 Inhibition and Apoptosis

Ten daily doses of venetoclax at ART start shrank the intact SIV reservoir in macaques

Emory researchers report in Nature Microbiology that ten days of an approved blood-cancer drug, given as antiretroviral therapy began, left the intact SIV reservoir smaller nine months later. No animal was taken off ART to test rebound.